Rectify Pharmaceuticals

Rectify Pharma specializes in developing Positive Functional Modulators (PFMs), a novel class of oral small molecules aimed at rectifying membrane protein dysfunction associated with serious diseases such as primary sclerosing cholangitis (PSC) and cardio-renal-metabolic disorders. Their proprietary PFM product platform facilitates the rapid discov... ery of therapies that enhance membrane protein function, targeting conditions linked to dysfunctional membrane proteins. The company's pipeline includes innovative treatments for a range of diseases, with a focus on improving patient outcomes in hepatobiliary and cardio-renal health. Rectify Pharma is committed to addressing the underlying causes of debilitating diseases through its advanced therapeutic approaches.Read More